Liver fat content was increased in newly diagnosed overweight patients with type 2 diabetes combined with nonalcoholic fatty liver disease (NAFLD) compared to individuals in the control group, and was associated with high levels of FGF21. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.